Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abcam plc stock logo
ABCZY
Abcam
$0.00
$11.26
$19.73
$3.98B1.294,712 shs5,400 shs
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$9.45
-0.1%
$10.03
$8.02
$18.80
$4.69B1.444.93 million shs4.40 million shs
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
$65.16
+2.8%
$77.51
$57.97
$141.74
$4.63B0.81950 shs758 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abcam plc stock logo
ABCZY
Abcam
0.00%0.00%0.00%0.00%0.00%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.00%+11.91%-9.09%-21.69%-28.73%
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
0.00%+0.52%-14.38%-39.10%-24.90%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abcam plc stock logo
ABCZY
Abcam
N/AN/AN/AN/AN/AN/AN/AN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
3.9021 of 5 stars
4.22.00.00.32.63.30.6
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abcam plc stock logo
ABCZY
Abcam
0.00
N/AN/AN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
2.43
Hold$14.6755.20% Upside
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
3.67
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest CU6, ZLDPF, ELAN, and ABCZY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/14/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $13.00
3/7/2025
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
3/6/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $12.00
2/27/2025
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
2/26/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $17.00
2/26/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $13.00
2/26/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$20.00 ➝ $19.00
2/21/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $16.00
1/29/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$15.00 ➝ $14.00
(Data available from 4/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abcam plc stock logo
ABCZY
Abcam
$336.37M0.00N/AN/AN/ANaN
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$4.44B1.06$1.95 per share4.84$12.63 per share0.75
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
$9.09M509.12N/AN/A$4.49 per share14.51
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abcam plc stock logo
ABCZY
Abcam
N/AN/A0.000.00N/AN/AN/AN/AN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
-$1.23B$0.6723.6310.622.504.60%6.78%3.03%5/7/2025 (Estimated)
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
-$102.18M-$2.36N/AN/AN/A-1,725.03%-15.24%-13.77%5/7/2025 (Estimated)

Latest CU6, ZLDPF, ELAN, and ABCZY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025N/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
-$0.77N/AN/AN/A$248.61 millionN/A
5/7/2025Q1 2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.31N/AN/AN/A$1.17 billionN/A
2/25/2025Q4 2024
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.15$0.14-$0.01-$0.02$1.01 billion$1.02 billion
2/20/2025Q4 2024
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
-$0.78-$0.59+$0.19-$0.59$28.11 million$1.30 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abcam plc stock logo
ABCZY
Abcam
$0.070.36%N/AN/AN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
N/AN/AN/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abcam plc stock logo
ABCZY
Abcam
N/AN/AN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.66
2.55
1.31
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
0.03
35.49
35.49

Institutional Ownership

CompanyInstitutional Ownership
Abcam plc stock logo
ABCZY
Abcam
N/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
97.48%
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/A

Insider Ownership

CompanyInsider Ownership
Abcam plc stock logo
ABCZY
Abcam
N/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.89%
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Abcam plc stock logo
ABCZY
Abcam
1,750205.08 millionN/ANot Optionable
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
9,800496.46 million491.54 millionOptionable
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
34071.02 millionN/ANot Optionable

Recent News About These Companies

Zealand Pharma appoints Utpal Singh as CSO
Zealand Pharma convenes its Annual General Meeting 2025

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abcam stock logo

Abcam OTCMKTS:ABCZY

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Germany, the United Kingdom, and internationally. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc has partnership with Cancer Research UK for the development and commercialization of novel custom antibodies to support the acceleration of cancer research. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Elanco Animal Health stock logo

Elanco Animal Health NYSE:ELAN

$9.45 -0.01 (-0.11%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$9.44 0.00 (-0.05%)
As of 04/25/2025 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Zealand Pharma A/S stock logo

Zealand Pharma A/S OTCMKTS:ZLDPF

$65.16 +1.80 (+2.84%)
As of 04/25/2025 12:35 PM Eastern

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.